Inquiry Question 1: How does technology contribute to scientific research and how do scientific advancements enhance technology?
Investigate how technological developments have enhanced scientific research, including a research facility such as a nuclear reactor or synchrotron
A focused answer to the HSC Investigating Science Module 6 dot point on the OPAL research reactor at ANSTO. Covers what the reactor does, nuclear medicine production, neutron scattering, and worked HSC past exam questions on technology enabling science.
Reviewed by: AI editorial process; not yet individually human-reviewed
Have a quick question? Jump to the Q&A page
Jump to a section
What this dot point is asking
NESA wants you to describe how a large-scale research facility enables scientific research that would otherwise be impossible, with a specific case study. The OPAL reactor at ANSTO is the recommended Australian example.
The answer
OPAL (Open Pool Australian Lightwater reactor) is Australia's national nuclear research reactor. Operated by ANSTO at Lucas Heights in southern Sydney since 2007, it produces nuclear medicine isotopes and provides neutron beams for materials research.
What OPAL is
OPAL is a 20 MW reactor that uses low-enriched uranium fuel (less than 20 per cent U-235, well below weapons-grade) cooled by light water. It replaced the older HIFAR reactor in 2007 and is one of about 50 research reactors operating worldwide. Importantly, OPAL is not a power reactor: it does not generate electricity. Its purpose is to produce neutrons.
What neutrons can do
Neutrons are neutral subatomic particles produced in the reactor's core. Two main uses:
1. Probing materials with neutron beams.
Unlike X-rays, neutrons pass through dense materials, are scattered by light elements like hydrogen and reveal atomic positions, magnetic moments and atomic vibrations. Eight neutron-beam instruments at OPAL serve fields from drug design to battery research.
Specific instruments at OPAL include:
- WOMBAT. A high-intensity diffractometer for fast atomic structure determination.
- KOWARI. A residual stress diffractometer used for engineering components and welds.
- PELICAN. Time-of-flight spectrometer for dynamics of magnetic and quantum materials.
- PLATYPUS. Reflectometer for thin films and interfaces.
2. Transmuting targets to produce radioisotopes.
Materials placed in the reactor are bombarded with neutrons, which converts stable isotopes into useful radioisotopes.
Nuclear medicine production
OPAL is the only Australian source of medical radioisotopes.
| Isotope | Use | Production |
|---|---|---|
| Molybdenum-99 (decays to technetium-99m) | Diagnostic imaging of heart, bone, brain | Approximately 10,000 doses/week |
| Iodine-131 | Treatment of thyroid cancer | Targeted radiotherapy |
| Lutetium-177 | Treatment of neuroendocrine and prostate cancer | Targeted radiotherapy |
| Yttrium-90 | Treatment of liver cancer | Targeted radiotherapy |
Technetium-99m alone is used in 80 per cent of all nuclear medicine procedures globally. About 700,000 scans per year in Australia depend on OPAL.
Other applications
- Silicon transmutation doping
- Pure silicon ingots are irradiated to convert a small fraction to phosphorus, producing semiconductor-grade silicon used in high-voltage electronics for solar arrays and electric vehicles. OPAL is one of the world's largest commercial doping services.
- Neutron activation analysis
- Trace elements can be detected at parts-per-billion sensitivity by activating samples and measuring the gamma rays emitted. Used for forensic science, archaeology and environmental monitoring.
- Indigenous artefact analysis
- Researchers have used OPAL's neutron techniques to study Aboriginal ochre samples and stone tools, identifying trade routes and pigment sources across the continent.
Scientific output
About 700 visiting scientists from Australian and international universities use OPAL's beam instruments each year. Output includes:
- Lithium-ion battery materials. Neutron diffraction of cathode materials at the University of Wollongong and ARC Centres of Excellence.
- Mining waste characterisation. Neutron techniques for tracking heavy-metal contamination.
- Pharmaceutical research. Drug crystal structure determination.
- Climate science. Ice-core dating using neutron activation.
Strategic and policy context
ANSTO's OPAL gives Australia:
- Independence from overseas supply of molybdenum-99. The Canadian NRU reactor (a major global supplier) shut down in 2018, causing global shortages. OPAL has helped stabilise supply.
- A neutron-science capability that universities cannot afford to build individually.
- A national nuclear science training facility.
Controversies
- Safety. OPAL is licensed by the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) and operates to international Atomic Energy Agency (IAEA) safeguards.
- Waste. Spent fuel is sent to France for reprocessing under a long-term agreement; intermediate-level waste remains at Lucas Heights pending a National Radioactive Waste Management Facility, which has been politically contested.
- Cost. OPAL cost approximately 400 million AUD to build, and ANSTO's annual budget is around 250 million AUD per year. Critics argue the cost is high relative to other research-funding options; supporters cite the irreplaceable medical isotope supply.
Examples in context
Example 1. OPAL technetium-99m supply during shutdowns. When OPAL underwent a planned three-month maintenance shutdown in 2018, ANSTO arranged molybdenum-99 imports from South Africa's SAFARI reactor and from Belgium's BR2 to maintain hospital supply. Hospital nuclear-medicine departments scheduled non-urgent scans around the shutdown, and the Commonwealth Department of Health temporarily expanded import licences. The episode exposed the global fragility of medical-isotope supply: only a small number of research reactors worldwide produce Mo-99, and unplanned outages at any one of them ripple through hospital schedules across continents. The case illustrates why governments treat OPAL as critical national infrastructure rather than as ordinary research equipment.
Example 2. OPAL neutron beam structural biology. The Australian Centre for Neutron Scattering at OPAL operates several beam-lines that biologists use to study proteins in their natural hydrated state, because neutrons (unlike X-rays) interact strongly with hydrogen and weakly damage biological samples. A 2023 study by Monash University researchers used the SANS instrument at OPAL to map structural changes in spider-silk proteins under tension, work that informed bio-inspired material design. Beam time is awarded by peer-reviewed proposal, with about 60 per cent of proposals from non-Australian researchers. The case shows that research facilities with no commercial output (neutron beams) enable scientific work that no other Australian instrument could perform.
Try this
Q1. Explain how OPAL produces technetium-99m for medical imaging. [3 marks]
- Cue. Neutron bombardment of uranium-235 produces molybdenum-99; Mo-99 decays (half-life 66 h) to Tc-99m which emits a clean gamma ray suitable for SPECT imaging.
Q2. A proposal to replace OPAL's Mo-99 production with cyclotron-produced Tc-99m is debated. Discuss one advantage and one limitation of the cyclotron approach. [3 marks]
- Cue. Advantage: no nuclear waste, smaller facility footprint. Limitation: lower yield per unit cost, distribution constrained by Tc-99m half-life (6 hours), requires many small cyclotrons rather than one reactor.
Q3. ANSTO holds public consultation about expanded waste storage at Lucas Heights. (a) Identify one ethical consideration. (b) Identify one piece of primary data the consultation might collect. (c) Identify one ARPANSA role in the process. [2+2+2 marks]
- Cue. (a) Intergenerational fairness; consent of nearby communities including Aboriginal stakeholders. (b) Submissions, public-meeting transcripts, survey responses. (c) Independent licensing and inspection; verification of radiation-protection standards.
Exam-style practice questions
Practice questions written in the style of NESA exam questions on this dot point, with worked answer explainers. The year tag is the paper they imitate, not the source.
2023 HSC5 marksDescribe how a research facility has enabled scientific research, using a specific example.Show worked answer →
A 5-mark answer needs the facility, its capabilities, examples of research enabled and the broader impact.
Facility. The OPAL (Open Pool Australian Lightwater) research reactor at the Australian Nuclear Science and Technology Organisation (ANSTO) Lucas Heights, Sydney. Operational since 2007 and replaced the HIFAR reactor.
Capabilities.
- Neutron beams for materials science. Neutrons probe materials at the atomic scale and reveal magnetic, structural and dynamic properties impossible to image otherwise.
- Radioisotope production. OPAL is the only Australian source of molybdenum-99 (which decays to technetium-99m for medical imaging), iodine-131, lutetium-177 and other diagnostic and therapeutic isotopes.
- Neutron activation analysis for trace element determination in environmental and archaeological samples.
- Silicon doping. Producing semiconductor-grade silicon for the electronics industry.
Research enabled. Materials research on lithium-ion batteries, magnetic shape-memory alloys, archaeological dating of Aboriginal artefacts, climate proxy research in ice cores.
Broader impact.
- 10,000+ nuclear medicine doses produced weekly for hospitals.
- Approximately 700 visiting scientists per year use the neutron beam facilities.
- Trains the next generation of Australian nuclear scientists.
Markers reward the named facility, multiple research applications and quantified impact.
2021 HSC4 marksExplain how nuclear medicine produced at OPAL contributes to medical diagnosis in Australia.Show worked answer →
A 4-mark answer needs the production, the medical use, the patient impact and a quantified contribution.
- Production
- OPAL irradiates targets with neutrons to produce radioisotopes that cannot be made by other means. The key isotope is molybdenum-99, which decays to technetium-99m, the workhorse of nuclear medicine. ANSTO produces approximately 10,000 doses per week.
- Medical use
- Technetium-99m is attached to pharmaceutical molecules that target specific organs (bone, heart, kidneys, brain). It emits gamma rays detectable by gamma cameras, producing diagnostic images of organ function rather than just structure.
- Patient impact
- A bone scan can detect cancer metastases earlier than CT or MRI. A myocardial perfusion scan reveals heart-attack damage. Roughly 700,000 nuclear medicine scans per year in Australia rely on OPAL-produced isotopes.
- Quantified contribution
- ANSTO supplies 100 per cent of Australian molybdenum-99 demand and exports to over 20 countries. The reactor reduces Australia's dependence on overseas supply, which has been disrupted multiple times since 2010.
Markers reward the production process, the medical mechanism, named scans and quantified output.
